FDA Drug Application (050475) for GRIS-PEG by VALEANT PHARMS INC

Back to FDA Applications sponsored by VALEANT PHARMS INC

Application Number050475
Product Number001
FormTABLET;ORAL
Dosage125MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameGRIS-PEG
Active IngredientGRISEOFULVIN, ULTRAMICROSIZE

Active IngredientCount
List of drugs with Active Ingredient GRISEOFULVIN, ULTRAMICROSIZE3


Back to FDA Applications sponsored by VALEANT PHARMS INC